Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Regul Pept ; 106(1-3): 19-26, 2002 Jun 15.
Article in English | MEDLINE | ID: mdl-12047906

ABSTRACT

The involvement of atrial natriuretic peptide (ANP) in the regulation of thyroid gland is supported by the presence of high-affinity ANP receptors and the identification of the peptide in thyroid follicular cells. The aim of this work was to study the action of ANP on parameters of thyroid hormone biosynthesis and analyze the intracellular mechanism of the ANP action in cultured bovine thyroid follicles. The addition of ANP (0.1-10 nM) to the culture medium for 24 h inhibited the TSH (thyroid-stimulating hormone)-stimulated iodide uptake with a maximal inhibition at 1 nM ANP. When thyrocytes were incubated with 10 nM ANP the inhibitory effect slightly increased from 24 to 72 h. Thyroglobulin (Tg) mRNA expression was reduced by 1 and 10 nM ANP. After 24 h of treatment with the cGMP analogue, N(2),2'-O-dibutyrylguanosine 3':5'-cyclic monophosphate [(Bu)(2)cGMP] (0.1 and 1 mM), an inhibition of iodide uptake and Tg mRNA expression was obtained, evidencing a cGMP-mediated inhibitory signal in the thyroid cell. A reduction of the cAMP production was induced by incubation of thyroid follicles with 1 and 10 nM ANP for 24 h. Under a similar treatment the cGMP accumulation was increased only by 10 nM ANP. The inhibitory effect of ANP on Tg mRNA level was reverted in the presence of pertussis toxin, an inhibitor of the G(i)-protein-mediated reduction of the adenylate cyclase activity. These results indicate an inhibitory action of ANP on parameters of thyroid hormone biosynthesis. A G(i)-protein-mediated reduction of the cAMP production seems to be the main factor involved in the ANP action although a role of the cGMP pathway should not be discarded specially at high ANP levels.


Subject(s)
Atrial Natriuretic Factor/pharmacology , Gene Expression Regulation/drug effects , Iodides/metabolism , Thyroglobulin/genetics , Thyroid Gland/drug effects , Animals , Biological Transport/drug effects , Cattle , Cells, Cultured , Cyclic AMP/metabolism , Cyclic GMP/metabolism , Pertussis Toxin/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/drug effects , Thyroid Gland/cytology , Thyroid Gland/metabolism , Thyroid Hormones/biosynthesis
2.
Mol Cell Endocrinol ; 181(1-2): 131-7, 2001 Jul 05.
Article in English | MEDLINE | ID: mdl-11476947

ABSTRACT

Since the transcription factor Zfhep is expressed in somatotropes and binds the rat growth hormone (rGH) gene T3-response element (TRE), we investigated whether Zfhep regulates the response of this gene to T3. In cotransfection experiments, Zfhep did not regulate the native rGH promoter in the absence of T3. However, Zfhep repressed T3-mediated activation significantly in either GH(3) or JEG-3 cells. Up to 70% repression was mediated through the rGH TRE in a heterologous promoter (thymidine kinase), but was not observed with the idealized DR4 or chicken lysozyme F2 TREs. Zfhep apparently does not repress T3-mediated activation simply by competition for binding to DNA since the C-terminal DNA-binding domain of Zfhep (which is sufficient for DNA-binding) is not sufficient for repression and since cotransfection of excess thyroid hormone receptor (TR) did not prevent repression by Zfhep. These data indicate that the rGH TRE is a composite element that can integrate Zfhep and T3 regulation.


Subject(s)
Growth Hormone/genetics , Homeodomain Proteins/chemistry , Homeodomain Proteins/metabolism , Transcription Factors/chemistry , Transcription Factors/metabolism , Transcriptional Activation/drug effects , Triiodothyronine/antagonists & inhibitors , Triiodothyronine/pharmacology , Zinc Fingers , Animals , Blotting, Western , Cell Line , Chickens , Chlorocebus aethiops , Genes, Reporter/genetics , Homeodomain Proteins/genetics , Promoter Regions, Genetic/genetics , Rats , Repressor Proteins/chemistry , Repressor Proteins/genetics , Repressor Proteins/metabolism , Response Elements/genetics , Sequence Deletion , Transcription Factors/genetics , Zinc Finger E-box-Binding Homeobox 1
3.
Thyroid ; 8(1): 71-80, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9492157

ABSTRACT

To establish biochemical and functional relations during thyroid development, the activity of thyroid peroxidase (TPO), nicotinamide adenine dinucleotide phosphate (NADPH)-cytochrome c reductase and monoamine oxidase (MAO) in a particulate fraction and the iodide transport and organification in slices of bovine fetal thyroid were examined throughout gestation. The cytochemical localization of TPO, H2O2 generating sites and MAO was also studied. Fetal glands were grouped in stages I to V according to increasing developmental features; adult tissues were also analyzed. TPO activity in each of the fetal stages was higher than in the adult; a marked increase was observed in stages IV and V. Iodide transport (T/M) was similar in stages I to V and the adult. Iodide organification in fetal thyroids showed a similar pattern to that of TPO activity. When compared with the adult, at midgestation (stages II to III), a lower iodination coexisted with a higher TPO activity. The activity of NADPH-cytochrome c reductase and MAO, two enzymes previously proposed to participate in thyroid H2O2 generation, did not parallel the level of iodide organification. Cells from stages II to V exhibited a positive cytochemical reaction for TPO in the rough endoplasmic reticulum (RER) and the perinuclear cisternae (PC). In stages IV, V, and adult, TPO was occasionally found in apical vesicles and microvilli, whereas H2O2 was detected within the RER and the PC. MAO reaction was positive in adult, but not in fetal thyroid. These results indicate that a high TPO activity accompanied the onset of the organification process during fetal thyroid development. The level of iodination was associated with the presence of TPO at a proper site rather than to the level of TPO activity. Evidence against a role of NADPH-cytochrome c reductase and MAO in the iodide organification was obtained.


Subject(s)
Fetus/physiology , Thyroid Gland/embryology , Animals , Biological Transport/physiology , Cattle/embryology , DNA/metabolism , Embryonic and Fetal Development/physiology , Fetus/metabolism , Histocytochemistry , Hydrogen Peroxide/metabolism , Iodide Peroxidase/metabolism , Iodides/metabolism , Monoamine Oxidase/metabolism , NADPH-Ferrihemoprotein Reductase/metabolism , Proteins/metabolism , Thyroid Gland/metabolism , Thyroid Gland/physiology
4.
Thyroid ; 8(12): 1127-35, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9920369

ABSTRACT

Nitric oxide (NO) has been proposed as an intracellular signal in the thyroid. The NO effect on function and morphology of bovine thyroid follicles in culture was analyzed by using the NO donors sodium nitroprusside (SNP) and S-nitrosoglutathione (GSNO). Both NO donors induced a concentration-dependent NO release measured by the nitrite accumulation in the culture medium. The SNP (10 to 500 micromol/L) treatment for 24 hours significantly inhibited the uptake, organification and transport of iodide in a concentration-dependent manner. When SNP (50 micromol/L) was withdrawn from the culture medium after 24 hours' incubation, iodide uptake and organification were partially recovered at 24 hours and reached the control value at 48 hours, indicating a reversible effect of SNP. A possible involvement of cyanide in the SNP inhibitory effect was excluded because incubation of follicles with potassium cyanide (KCN) at concentrations estimated to be present in the medium (40 and 80 micromol/L) for 24 hours did not modify iodide uptake and organification. The GSNO (10 to 500 micromol/L) treatment for 24 hours also reduced the iodide uptake, organification and transport in a concentration-dependent manner. A significant inhibition of iodide organification was induced after incubation with 1000 micromol/L of N2, 2'-O-dibutyrylguanosine 3':5'-cyclic monophosphate ([Bu]2cGMP). Morphological evaluation by light microscopy revealed that the incubation with NPS or GSNO (500 micromol/L) produced cellular dispersion with loss of follicular cell aggregates that was evident at 96 hours exposure. Cell viability was not altered by 10-500 micromol/L SNP or GSNO (80% to 85%). We concluded that long-term NO exposure induces functional and morphological modifications compatible with a loss of differentiation in thyroid follicles. These observations further support a role of NO in the regulation of the thyroid function.


Subject(s)
Iodides/metabolism , Nitric Oxide Donors/pharmacology , Thyroid Gland/cytology , Thyroid Gland/drug effects , Animals , Biological Transport/drug effects , Cattle , Cells, Cultured , Culture Media , Dibutyryl Cyclic GMP/pharmacology , Glutathione/analogs & derivatives , Glutathione/pharmacology , Nitric Oxide/biosynthesis , Nitrites/metabolism , Nitroprusside/pharmacology , Nitroso Compounds/pharmacology , Potassium Cyanide/pharmacology , S-Nitrosoglutathione , Thyroid Gland/metabolism
5.
DNA Cell Biol ; 15(8): 643-51, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8769566

ABSTRACT

We have previously isolated a cDNA for a transcription factor referred to as Zfhep (zinc finger homeodomain enhancer-binding protein) containing two separate zinc finger domains, ZD1 and ZD2, each of which binds DNA, and a homeodomain. The rat Zfhep cDNA lacks a 5'-methionine codon, present in some homologs from other species. Hence, the aim of this work was to isolate the 5'-end of the rat Zfhep cDNA. Zfhep-2 cDNA was isolated, having a total length of 2.5 kbp, including more than 1.1 kbp of novel sequence followed by 1.4 kbp identical to the Zfhep-1 clone. The 1.1 kbp of novel sequence contains multiple stop codons in all reading frames, suggesting that it represents the 5'-untranslated (5'-UT) region of the rat Zfhep-2 mRNA. However, the Zfhep-2 clone does not contain the extreme 5'-exon(s) of the Zfhep-1 coding sequence, possibly due to alternative splicing of Zfhep RNA. To distinguish between a splice junction versus an intron-exon junction, the polymerase chain reaction (PCR) with rat genomic DNA and junction-flanking primers from the Zfhep-2 sequence was conducted. No bands were amplified from the genomic DNA by two different pairs of primers, indicating that the Zfhep-2-specific sequence is not intronic. Ribonuclease protection assays were performed to investigate the expression of multiple Zfhep mRNAs. Two protected bands were detected, and both were identified in total RNA or mRNA of rat ovary, hindbrain, forebrain, heart, kidney, small intestine, and GH4C1 cells. Zfhep-2 represents about 20% of the Zfhep RNA in each tissue. Hence, two mRNAs are expressed in these tissues, confirming the alternative splicing. To confirm independently the presence of both Zfhep-2 and Zfhep-1 mRNAs, reverse transcriptase (RT)-PCR was done using primers that span the Zfhep splice site. Specific bands representing both RNAs were obtained. The Zfhep-2 PCR product was subcloned and DNA sequence analysis confirmed the absence of ATG codons near the 5'-end of the open reading frame. The theoretical translation of the Zfhep-2 clone predicts a smaller protein than Zfhep-1. In vitro translation in reticulocyte lysates showed that Zfhep-2 is about 40 kD smaller than Zfhep-1. Hence, Zfhep-2 apparently lacks most of the first zinc finger domain (ZD1) of Zfhep-1. Because the two zinc finger domains bind different DNA sequences, Zfhep-2 is predicted to bind to only a subset of genes recognized by Zfhep-1.


Subject(s)
Alternative Splicing , Homeodomain Proteins/genetics , RNA, Messenger/genetics , Transcription Factors/genetics , Triiodothyronine , Zinc Fingers , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA/genetics , DNA, Complementary/genetics , Gene Expression , Homeodomain Proteins/biosynthesis , Homeodomain Proteins/chemistry , Molecular Sequence Data , Molecular Weight , Open Reading Frames , Organ Specificity , RNA, Complementary , RNA, Messenger/analysis , Rats , Regulatory Sequences, Nucleic Acid , Sequence Analysis, DNA , Transcription Factors/biosynthesis , Transcription Factors/chemistry , Zinc Finger E-box-Binding Homeobox 1
6.
Eur J Endocrinol ; 134(2): 215-20, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8630522

ABSTRACT

Triiodothyronine (T3) is involved in the regulation of the growth hormone-insulin-like growth factor I (GH-IGF-I) axis. In this study we investigated the effect of GH and IGF-I on the metabolic response of T3 in target tissues by evaluating the activity of two T3-dependent liver enzymes: mitochondrial alpha-glycerophosphate dehydrogenase (alpha-GPD) and cytosolic malic enzyme (ME) in rat hepatocytes in primary culture. Growth hormone (35 nmol/l) as well as IGF-I (0.5 mumol/l) reduced alpha-GPD and ME activities (p < 0.01) compared to the control group. Timecourse studies indicated that IGF-I (1.5 mumol/l) significantly decreased alpha-GPD and ME activities (P < 0.01) after 24 h, whereas the effect of GH (35 nmol/l) was recorded only after 36 h (p < 0.01). This delayed effect of GH compared to IGF-I suggested the possibility that the effect of GH could be mediated by IGF-I synthesis. To test this hypothesis, the effect of GH on the two enzyme activities was studied in the presence of anti-IGF-I antibodies. A gradual recovery of alpha-GPD and ME activities (p < 0.01) was observed in the presence of GH (35 nmol/l) plus increasing concentrations of anti-IGF-I antiserum. The maximal alpha-GPD and ME activities attained after the incubation of the liver cells with 1 mumol/l T3, a concentration high enough to fully saturate the nuclear T3 receptors for 24 h, were lowered significantly by 1.0 mumol/l IGF-I (p < 0.01). This finding suggests that the IGF-I effect might be independent of the saturation of the nuclear T3 receptors. In conclusion, in cultured rat hepatocytes, GH and IGF-I reduced the metabolic response of T3 evaluated by two liver T3-dependent enzyme activities. The effect of GH was mediated at least in part by IGF-I.


Subject(s)
Glycerolphosphate Dehydrogenase/metabolism , Growth Hormone/pharmacology , Insulin-Like Growth Factor I/pharmacology , Liver/enzymology , Malate Dehydrogenase/metabolism , Triiodothyronine/pharmacology , Animals , Cells, Cultured , Cytosol/enzymology , Enzyme Inhibitors/pharmacology , Immune Sera/pharmacology , Insulin-Like Growth Factor I/antagonists & inhibitors , Insulin-Like Growth Factor I/immunology , Liver/drug effects , Male , Mitochondria, Liver/enzymology , Rats , Rats, Wistar
7.
J Endocrinol ; 143(2): 303-8, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7829993

ABSTRACT

The present work was addressed to study a possible relationship between monoamine oxidase (MAO) and the thyroid iodide transport mechanism. Normal rats treated with clorgyline (a selective MAO-A inhibitor) or tranylcypromine (a non-selective MAO inhibitor) showed a significantly diminished thyroid MAO activity, while deprenyl and pargyline (MAO-B inhibitors) did not modify the thyroidal enzyme activity with respect to the control group. Under these conditions, in vivo iodide transport was reduced both by clorgyline and tranylcypromine administration whereas it remained unchanged after treatment with MAO-B inhibitors. The effect of MAO inhibitors on thyroid MAO activity and in vivo iodide transport was also evaluated in rats treated with exogenous thyrotrophin (TSH) after endogenous TSH secretion blockade produced by T4 administration. In this condition, thyroid MAO activity was significantly lowered by clorgyline and was not modified by deprenyl. In contrast to the results observed in normal rats, in vivo iodide transport in TSH-treated rats remained unaltered after treatment either with clorgyline or deprenyl. MAO activity evaluated in bovine thyroid follicles in primary culture was highly sensitive to low concentrations of clorgyline (< 10 nmol/l) and relatively insensitive to deprenyl, a finding that indicates a predominance of the MAO-A isoform in the follicular cells in culture. When clorgyline (0.1 and 1 mumol/l) or deprenyl (1 mumol/l) were added to the culture medium, no modifications in the active transport of iodide were observed. These results indicate the absence of a direct linkage between thyroid MAO activity and the active iodide transport.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Iodides/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Thyroid Gland/metabolism , Animals , Biological Transport/drug effects , Clorgyline/pharmacology , Male , Organ Culture Techniques , Pargyline/pharmacology , Rats , Rats, Wistar , Selegiline/pharmacology , Thyroid Gland/drug effects , Tranylcypromine/pharmacology
8.
J Clin Endocrinol Metab ; 79(1): 39-44, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8027249

ABSTRACT

Several biochemical and functional modifications demonstrated in goitrous tissues could reflect the effect of goitrogenic factors. Growth-enhancing agents, including TSH itself, have been involved in goitrogenesis. To study comparatively the variation patterns of some TSH-dependent enzymes within single goitrous tissues, we measured the activities of peroxidase (TPO), NADPH-cytochrome-c (cyt-c) reductase, and monoamine oxidase (MAO) in tissues from cold follicular adenoma and multinodular goiter. Iodide transport and organification were also evaluated. Perinodular and necropsy tissues were used as controls. The mean TPO activity measured by guaiacol as well as triiodide assays was significantly increased in multinodular goiter, whereas a nonsignificant increment was observed in cold adenoma. NADPH-cyt-c reductase and MAO were markedly increased in the two types of pathological tissues. The individual activities of the three enzymes showed dissimilar modifications within single samples and among different tissues. There was no correlation in the activities of the enzymes within single specimens from cold adenoma and multinodular goiter, except for MAO and NADPH-cyt-c reductase in multinodular goiter, for which a significant correlation was obtained. In this tissue, MAO and TPO measured by guaiacol assay were weakly correlated. TPO activity evaluated by guaiacol oxidation was correlated with that measured by triiodide formation in cold adenoma, but not in multinodular goiter. The mean iodide organification values assayed by iodotyrosine formation in the absence of exogenous H2O2 in particulate fractions from cold adenoma and multinodular goiter were within the normal range. A reduced iodide transport, evaluated as the thyroid/medium ratio, was observed in slices from these tissues. The dissociation of the three enzyme activities in single specimens from cold adenoma and multinodular goiter along with the reduced iodide transport in these tissues support the hypothesis that factors other than TSH or with TSH-like effects could be involved in the abnormal thyroid growth.


Subject(s)
Adenoma/enzymology , Goiter, Nodular/enzymology , Iodides/metabolism , Thyroid Neoplasms/enzymology , Thyrotropin/pharmacology , Biological Transport , DNA/metabolism , Humans , Iodide Peroxidase/metabolism , Monoamine Oxidase/metabolism , NADPH-Ferrihemoprotein Reductase/metabolism , Thyroid Gland/enzymology
9.
J Endocrinol ; 131(1): 25-31, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1660515

ABSTRACT

The characteristics and regulation of monoamine oxidase (MAO) were studied in rat thyroid tissue. A measured Michaelis constant (Km) value of 102 mumol/l was similar to the Km values found in other tissues. Maximal velocity (Vmax) was 1.028 nmol/mg protein per min. It is known that MAO is present as two isoenzymes, A and B, which are sensitive to clorgyline and deprenyl respectively. The in-vitro effect of graded concentrations of these selective MAO inhibitors was used to estimate the relative proportion of A and B isoenzymes. Clorgyline strongly decreased thyroid MAO activity at concentrations as low as 1 pmol/l while the effect of deprenyl was observed only at concentrations higher than 10 mumol/l. These results indicated that MAO-A is the main form of the enzyme in the rat thyroid. In-vivo administration of L-thyroxine (5.6-224 nmol/kg) significantly reduced thyroid MAO activity at doses equal to or greater than those which have been reported to inhibit iodine output from the thyroid. Increased TSH levels, induced either by exogenous TSH or methimazole administration, resulted in a significant increase in thyroid MAO activity. Theophylline, a phosphodiesterase inhibitor and dibutyryl cyclic AMP were also able to stimulate MAO activity when administered in vivo. Iodide organification (protein-bound 131I) in vivo as well as the relative proportion of the different thyroid iodo-compounds were not affected in animals with reduced or increased thyroid MAO activity induced by clorgyline or theophylline respectively. It was concluded that rat thyroid MAO activity is under the influence of TSH.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Iodides/metabolism , Isoenzymes/metabolism , Monoamine Oxidase/metabolism , Thyroid Gland/enzymology , Thyrotropin/physiology , Animals , Bucladesine/pharmacology , Clorgyline/pharmacology , Depression, Chemical , Male , Methimazole/pharmacology , Rats , Rats, Inbred Strains , Selegiline/pharmacology , Theophylline/pharmacology , Thyroid Gland/drug effects , Thyroid Gland/metabolism , Thyroxine/pharmacology
10.
Horm Metab Res ; 22(2): 80-4, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2323731

ABSTRACT

Monoamines are able to increase the thyroid iodine organification in vitro. A predominance of the A form of monoamine oxidase (MAO) has been previously demonstrated to exist in bovine thyroid tissue. In the present study we have investigated the form of MAO that could be involved in the iodotyrosine formation induced by tyramine, 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PEA) in a bovine thyroid subcellular fraction. The relative capacity of these monoamines to generate H2O2 and to incorporate iodine into tyrosine has also been studied. The MAO A inhibitor clorgyline (10(-9) M) produced a strong inhibition on the iodotyrosine formation induced by tyramine, 5-HT and PEA. In contrast, only a slight reduction was observed with deprenyl as MAO B inhibitor. Among the three monoamines, tyramine produced the highest H2O2 generation and iodotyrosine formation. The lowest Km value obtained was for 5-HT and the highest for PEA. Regarding the Vmax, the lowest value was for 5-HT and the highest for tyramine. The amount of iodine incorporated to tyrosine was not equivalent to the H2O2 generated by the monoamines nor to that exogenously added. Our results indicate that in bovine thyroid tissue mainly the A form of MAO is involved in the monoamine metabolism.


Subject(s)
Monoamine Oxidase/metabolism , Monoiodotyrosine/biosynthesis , Phenethylamines/pharmacology , Serotonin/pharmacology , Thyroid Gland/metabolism , Tyramine/pharmacology , Animals , Cattle , Clorgyline/pharmacology , Hydrogen Peroxide/metabolism , Iodine/metabolism , Monoamine Oxidase Inhibitors/pharmacology , Monoiodotyrosine/antagonists & inhibitors , Substrate Specificity , Thyroid Gland/enzymology
11.
Clin Endocrinol (Oxf) ; 30(6): 681-6, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2556223

ABSTRACT

Monoamine oxidase (MAO) activity and its forms were measured in normal human thyroid glands (39 samples from necropsy and four from perinodular tissues) and in pathological thyroid glands (13 multinodular goitres, three carcinomas, seven chronic thyroiditis, five Graves' disease and seven follicular, seven foetal and five embryonal adenomas). MAO activity in carcinomas was lower than in normal perinodular thyroid control tissue; in Graves' disease, foetal and embryonal adenomas it was significantly higher than in the normal control. The use of clorgyline (a selective MAO A inhibitor) and deprenyl (selective MAO B inhibitor) allowed estimation of the relative proportion of MAO forms. A high proportion of MAO A (more than 90%) was observed, both in normal and in pathological thyroid tissues. Changes in total thyroid MAO activity, but not in its forms, were found in different pathologies of the thyroid gland.


Subject(s)
Monoamine Oxidase/metabolism , Thyroid Diseases/enzymology , Thyroid Gland/enzymology , Adenoma/enzymology , Carcinoma/enzymology , Clorgyline/pharmacology , Humans , Monoamine Oxidase Inhibitors/pharmacology , Neoplasms, Germ Cell and Embryonal/enzymology , Reference Values , Selegiline/pharmacology , Thyroid Neoplasms/enzymology
12.
Horm Metab Res ; 18(11): 750-3, 1986 Nov.
Article in English | MEDLINE | ID: mdl-3098663

ABSTRACT

Two functional forms of monoamine oxidase (MAO) defined as MAO A and MAO B have been described in several tissues. In this study the characteristics of MAO present in a particulate subcellular fraction of bovine thyroid tissue were investigated. The selective inhibitors of MAO, clorgyline (A form) and deprenyl (B form) were used. The monoamines 5-hydroxytryptamine (5-HT) (preferred of the A form), tyramine (both forms) and beta-phenylethylamine (PEA) (B Form) were used as substrates. MAO activity towards 5-HT was markedly inhibited by clorgyline. Tyramine oxidation was very sensitive to clorgyline and the curve obtained was in accordance with the presence of a high proportion of the A form. MAO activity towards PEA was also markedly inhibited by clorgyline. Deprenyl was not able to induce modifications in the MAO activity except when it was used at very high concentrations. According to these results the bovine thyroid tissue contains predominantly the A form of MAO. In this tissue PEA was deaminated by the A form of the enzyme.


Subject(s)
Monoamine Oxidase/metabolism , Thyroid Gland/enzymology , Animals , Biogenic Amines/metabolism , Cattle , Clorgyline/pharmacology , Phenethylamines , Selegiline/pharmacology , Serotonin , Subcellular Fractions/metabolism , Substrate Specificity , Thyroid Gland/metabolism , Tyramine
SELECTION OF CITATIONS
SEARCH DETAIL
...